Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter and full year ended December 31, 2013.
Management Commentary
“Anika concluded a record year for revenue and earnings, driven by solid demand for our viscosupplementation products as well as productivity improvements in operations and manufacturing,” said Charles H. Sherwood, Ph.D., President and Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
